173
Views
5
CrossRef citations to date
0
Altmetric
Articles

In-house validation of a liquid chromatography–tandem mass spectrometry method for the determination of selective androgen receptor modulators (SARMS) in bovine urine

&
Pages 1292-1304 | Received 14 Feb 2018, Accepted 18 Apr 2018, Published online: 01 Jun 2018

References

  • Cawley AT, Smart C, Greer C, Liu Lau M, Keledjian J. 2016. Detection of the selective androgen receptor modulator andarine (S-4) in a routine equine blood doping control sample. Drug Test Anal. 8:257–261.
  • Cesbron N, Sydor A, Penot M, Prevost S, Le Bizec B, Dervilly-Pinel G. 2017. Analytical strategies to detect enobosarm administration in bovines. Food Addit Contam Part A. 34:632–640.
  • Chen J, Kim J, Dalton JT. 2005. Discovery and therapeutic promise of selective androgen receptor modulators. Mol Intervent. 5:173–188.
  • Chen Y, Zhao L, Lu F, Yu Y, Chai Y, Wu Y. 2009. Determination of synthetic drugs used to adulterate botanical dietary supplements using QTRAP LC–MS/MS. Food Addit Contam. 26:595–603.
  • Cox HD, Eichner D. 2017. Detection of LGD-4033 and its metabolites in athlete urine samples. Drug Test Anal. 9:127–134.
  • Dalton JT, Miller DD, Kearbey J. 2010. SARMs and method of use thereof. US 20100249228A1. United States Patent Application Publication 75.
  • Dalton JT, Mukherjee A, Zhu Z, Kirkovsky L, Miller DD. 1998. Discovery of nonsteroidal androgens. Biochem Biophys Res Commun. 244:1–4.
  • De Rijke E, Essers ML, Rijk JC, Thevis M, Bovee TF, Van Ginkel LA, Sterk SS. 2013. Selective androgen receptor modulators: in vitro and in vivo metabolism and analysis. Food Add Contam Part A. 30:1517–1526.
  • [EC] European Commission. 1996a. Council directive 96/22/EC of 29 April 1996 concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyreostatic action and of beta-agonists (1996). Off J Eur Commun. L 125:3–9. 1996. Including its amending Directive 2003/74/EC concerning the prohibition on the use in stockfarming of certain substances having a hormonal or thyreostatic action and of beta-agonists.
  • [EC] European Commission. 1996b. Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products (1996). Off J Eur Commun. L 125:10–32.
  • [EC] European Commission. 2002a. Commission regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in matters of food safety. Off J Eur Commun L. 31:1–24.
  • [EC] European Commission. 2002b. Commission decision 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (2002). Off J Eur Commun. L221:8.
  • [EC] European Commission. 2004. Commission regulation (EC) No. 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (2004). Off J Eur Commun L. 165:1–141.
  • [EC] European Commission. 2008. Document SANCO 2726/2004 rev. 4, Guidelines for the Implementation of Decision 2002/657/EC, http://ec.europa.eu/food/food/chemicalsafety/residues/guidelines_2002-657.pdf.
  • Gao W, Dalton JT. 2007. Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs). Drug Discov Today. 12:241–248.
  • Gowik P, Polzer J, Uhlig S. 2007. Reference material in residue control: assessment of matrix effects. Accred Qual Assur. 12:161–166.
  • Grata E, Perrenoud L, Saugy M, Baume N. 2011. SARM-S4 and metabolites detection in sports drug testing: a case report. Forensic Sci Int. 213:104–108.
  • Jülicher B, Gowik P, Uhlig S. 1998. Assessment of detection methods in trace analysis by means of a statistically based in-house validation concept. Analyst. 123:173–179.
  • Jülicher B, Gowik P, Uhlig S. 1999. A top-down in-house validation based approach for the investigation of the measurement uncertainty using fractional factorial experiments. Analyst. 124:537–545.
  • Kaufmann A, Widmer M, Maden K. 2014. Signal suppression can bias selected reaction monitoring ratios. Implications for the confirmation of positive findings in residue testing. Rapid Commun Mass Spectrom. 28:899–907.
  • Kim J, Wang R, Veverka KA, Dalton JT. 2013. Absorption, distribution, metabolism and excretion of the novel SARM GTx-024 [(S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide] in rats. Xenobiotica. 43:993–1009.
  • Lamberty A, Schimmel H, Pauwels. 1998. The study of the stability of reference materials by isochronous measurements. J Fres J Anal Chem. 360:359–361.
  • Matraszek-Zuchowska I, Wozniak B, Posyniak A. 2016. Comparison of the multiple reaction monitoring and enhanced product ion scan modes for confirmation of stilbenes in bovine urine samples using LC–MS/MS QTRAP® System. Chromatographia. 79:1003–1012.
  • Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M. 2005. Development of a multi-target screening analysis for 301 drugs using a QTRAP liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom. 19:1332–1338.
  • Rojas D, Dervilly-Pinel G, Cesbron N, Penot M, Sydor A, Prévost S, Le Bizec B. 2017. Selective androgen receptor modulators: comparative excretion study of bicalutamide in bovine urine and faeces. Drug Test Anal. 9:1017–1025.
  • Schmidt K, Stachel C, Gowik P. 2008. Development and in-house validation of an LC–MS/MS method for the determination of stilbenes and resorcylic acid lactones in bovine urine. Anal Bioanal Chem. 391:1199–1210.
  • Schmidt KS, Stachel CS. 2013. In-house validation and factorial effect analysis of a liquid chromatography–tandem mass spectrometry method for the determination of steroids in bovine plasma. Food Add Cont. 405:6287–6297.
  • Schmidt KS, Stachel CS, Gowik P. 2009. In-house validation and factorial effect analysis of a liquid chromatography-tandem mass spectrometry method for the determination of steroids in bovine muscle. Anal Chim Acta. 637:156–164.
  • Scientific committee on Veterinary Measures Relating to Public Health. 2002. Opinion of the scientific committee on veterinary measures relating to public health on review of previous SCVPH opinions of 30 April 1999 and 3 May 2000 on the potential risks to human health from hormone residues in bovine meat and meat products (accessed 10 April 2002), https://ec.europa.eu/food/safety/chemical_safety/meat_hormones_en.
  • Starcevic B, Ahrens BD, Butch AW. 2013. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample. Drug Test Anal. 5:377–379.
  • Thevis M, Geyer H, Kamber M, Schänzer W. 2009. Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product. Drug Test Anal. 1:387–392.
  • Thevis M, Lagojda A, Kuehne D, Thomas A, Dib J, Hansson A, Hedeland M, Bondesson U, Wigger T, Karst U, et al. 2015. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing. Rapid Commun Mass Spectrom. 29:991–999.
  • Thevis M, Schänzer W. 2007. Emerging drugs-potential for misuse in sport and doping control detection strategies. Mini-Rev Med Chem. 7:531–537.
  • Thevis M, Schänzer W. 2010. Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators. Handb Exp Pharmacol. 195:99–126, and references cited.
  • Thevis M, Thomas A, Möller I, Geyer H, Dalton JT, Schänzer W. 2011. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls. Rapid Commun Mass Spectrom. 25:2187–2195.
  • Vanoosthuyze K, Daeseleire E, Van Overbeke A, Van Peteghem C, Ermens A. 1994. Survey of the hormones used in cattle fattening based on the analysis of Belgian injection sites. Analyst. 119:2655–2658.
  • World Anti-Doping Agency, 2016. The 2016 Prohibited List; accessed 2018 Feb 14]. https://wada-mainprod. s3.amazonaws.com/resources/files/wada-2016-prohibited-list-en.pdf, 04-01-2016.
  • Yager JD. 2015. Mechanisms of estrogen carcinogenesis: the role of E2/E1 – quinone metabolites suggests new approaches to preventive intervention – a review. Steroids. 99:56–60.
  • You Y, Uboh CE, Soma LR, Guan F, Li X, Rudy JA, Liu Y, Chen J. 2009. Ultra-performance liquid chromatography/tandem mass spectrometry in high-throughput detection, quantification and confirmation of anabolic steroids in equine plasma. Rapid Commun Mass Spectrom. 23:2035–2044.
  • Zhang X, Sui Z. 2013. Deciphering the selective androgen receptor modulators paradigm. Expert Opin Drug Discov. 8:191–218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.